compass therapeutics logo

Compass Therapeutics LLC

Compass Therapeutics (formerly known as Kairos Biologics) is an antibody R&D company focused on comprehensively drugging the tumor-immune synapse with combinations of human monoclonal antibodies, multiclonals and engineered protein constructs. It is located at JLABS @ LabCentral.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttps://www.compasstherapeutics.com
Founded2013
Disease Focus
Development Stage
STOCK CODENon Listed
Address
245 First Street 3rd Floor,MA 02142
Cambridge
United States
Email
Contact Number

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/compass-therapeutics-llc” connections=”true” suffix=””]

Compass Therapeutics proprietary Targeted Immunomodulation_ platform, which combines and enginer the best antibody leads by Comprehensively drugging the tumor-immune synapse with human antibodies against over 50 cell surface and soluble targets.

In 2015, Compass raised $120 Mn in Series A financing round lead by OrbiMed Advisors, Fidelity Biosciences, Borealis Ventures, Google Ventures and a handful of smaller VCs and angel investors.